Related Experiment Videos
Human d-amphetamine drug discrimination: methamphetamine and hydromorphone
1Hahnemann University, Philadelphia, Pennsylvania 19102-1192.
Journal of the Experimental Analysis of Behavior
|March 1, 1994
Summary
Drug discrimination tasks reveal that while some drug effects align with self-reports, others do not. This research compares behavioral and subjective drug responses for better understanding psychoactive drug effects.
Area of Science:
- Psychopharmacology
- Behavioral Neuroscience
- Drug Abuse Research
Background:
- Standard subjective measures and drug discrimination procedures are key tools in psychopharmacology.
- Understanding the relationship between discriminative stimulus control and subjective drug effects is crucial for drug research.
Purpose of the Study:
- To compare standard subjective measures with drug discrimination effects in human volunteers.
- To investigate how different drugs (d-amphetamine, methamphetamine, hydromorphone) affect behavior and self-reported experiences.
Main Methods:
- Human volunteers were trained on a second-order color-tracking procedure using d-amphetamine as a discriminative stimulus.
- Subjects completed questionnaires (single-dose, Addiction Research Center Inventory, analogue scales) to assess subjective effects.
- Doses of d-amphetamine, methamphetamine, and hydromorphone were administered, and responses were recorded.
Main Results:
- Methamphetamine and d-amphetamine increased responding appropriate to d-amphetamine and were identified as "speed."
- Hydromorphone did not increase d-amphetamine-appropriate responding but was identified as "dope."
- All tested drugs increased "drug liking" and specific Addiction Research Center Inventory scales.
Conclusions:
- Drug discrimination can predict some subjective effects (like drug identification) but not all.
- Combining drug discrimination with subjective measures offers a comprehensive approach to studying psychoactive drugs.
- This methodology aids in characterizing novel compounds and understanding the behavioral biology of drugs.